Cryolife Inc (NYSE:CRY) Sentiment Improved in Q4 2017

April 17, 2018 - By Hazel Jackson

CryoLife, Inc. (NYSE:CRY) Logo

Sentiment for Cryolife Inc (NYSE:CRY)

Cryolife Inc (NYSE:CRY) institutional sentiment decreased to 1.33 in Q4 2017. Its down -0.26, from 1.59 in 2017Q3. The ratio is negative, as 57 hedge funds opened new and increased holdings, while 43 trimmed and sold equity positions in Cryolife Inc. The hedge funds in our partner’s database now possess: 24.23 million shares, up from 23.69 million shares in 2017Q3. Also, the number of hedge funds holding Cryolife Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 14 Reduced: 29 Increased: 44 New Position: 13.

CryoLife, Inc., together with its subsidiaries, makes and distributes medical devices worldwide. The company has market cap of $851.67 million. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. It has a 217.29 P/E ratio. The firm operates in two divisions, Medical Devices and Preservation Services.

The stock increased 4.49% or $1 during the last trading session, reaching $23.25. About 89,900 shares traded. CryoLife, Inc. (NYSE:CRY) has risen 19.34% since April 17, 2017 and is uptrending. It has outperformed by 7.79% the S&P500.

Analysts await CryoLife, Inc. (NYSE:CRY) to report earnings on April, 25. They expect $-0.04 EPS, down 144.44 % or $0.13 from last year’s $0.09 per share. After $0.11 actual EPS reported by CryoLife, Inc. for the previous quarter, Wall Street now forecasts -136.36 % negative EPS growth.

Thomson Horstmann & Bryant Inc holds 0.86% of its portfolio in CryoLife, Inc. for 339,410 shares. Elk Creek Partners Llc owns 645,333 shares or 0.73% of their US portfolio. Moreover, Nbw Capital Llc has 0.42% invested in the company for 84,173 shares. The Pennsylvania-based Connors Investor Services Inc has invested 0.29% in the stock. Next Century Growth Investors Llc, a Minnesota-based fund reported 74,850 shares.#img1#

Since January 1, 0001, it had 0 insider purchases, and 3 selling transactions for $169,448 activity.

CryoLife, Inc. (NYSE:CRY) Ratings Coverage

Ratings analysis reveals 100% of Cryolife’s analysts are positive. Out of 2 Wall Street analysts rating Cryolife, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $23.5 while the high is $28.0. The stock’s average target of $25.75 is 10.75% above today’s ($23.25) share price. CRY was included in 4 notes of analysts from October 31, 2017. The firm has “Buy” rating by Canaccord Genuity given on Thursday, March 8. As per Monday, November 13, the company rating was maintained by Northland Capital. The stock of CryoLife, Inc. (NYSE:CRY) has “Buy” rating given on Tuesday, January 2 by Canaccord Genuity. Canaccord Genuity maintained it with “Buy” rating and $25.0 target in Tuesday, October 31 report.

CryoLife, Inc. (NYSE:CRY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: